Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PET Positive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableTemporarily Not AvailableNCT06980506
What this trial is testing

MNPR-101-DFO*-89Zr Expanded Access Program (EAP) for Patients With Solid Tumor Cancer

Who this might be right for
CancerSolid TumorSolid Tumor, Adult
Monopar Therapeutics
Early research (Phase 1)Study completedNCT02345174
What this trial is testing

Immuno Positron Emission Tomography Study of GSK2849330 in Subjects With Human Epidermal Growth Factor Receptor 3-Positive Solid Tumors

Who this might be right for
CancerNeoplasms
GlaxoSmithKline 6
Not applicableEnded earlyNCT00835783
What this trial is testing

Validation Study of Combined Positron Emission Tomography/Computer Tomography to Diagnose Infection and Inflammation

Who this might be right for
Bacterial InfectionsBacteremiaGram-Positive Bacterial Infections+1 more
Odense University Hospital 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT01937117
What this trial is testing

Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 88
Early research (Phase 1)Ended earlyNCT02095210
What this trial is testing

HER2 PET Imaging in Breast Cancer Patients Using [68GA]ABY-025

Who this might be right for
HER2-positive Breast Cancer
Dorte Nielsen 2
Post-approval studies (Phase 4)Looking for participantsNCT04081701
What this trial is testing

68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.

Who this might be right for
CNS TumorsMeningiomaEsthesioneuroblastoma+4 more
Weill Medical College of Cornell University 200
Testing effectiveness (Phase 2)Ended earlyNCT00590967
What this trial is testing

A Phase II Study of Extended Field IMRT External Beam Irradiation and Intracavitary Brachytherapy

Who this might be right for
Cervical Cancer
Washington University School of Medicine 69
Not applicableStudy completedNCT00828126
What this trial is testing

PET-CT in the Management of Patients With Stage III or IV Metastatic Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 38
Not applicableStudy completedNCT03695861
What this trial is testing

Contribution of 18F-FDG PET-CT in the Diagnosis and the Detection of Peripheral Emboli of Infectious Endocarditis on Native Valves

Who this might be right for
Endocarditis
University Hospital, Bordeaux 31
Not applicableUnknownNCT04977128
What this trial is testing

89Zr-labeled KN035 PET Imaging in Patients With PD-L1 Positive Solid Tumors

Who this might be right for
Solid Tumor, Adult
Wuxi No. 4 People's Hospital 20
Not applicableStudy completedNCT06344767
What this trial is testing

Positive ER Expression Assessed by 18F-FES PET/CT in the MBC with ER-negative Primary Tumor

Who this might be right for
Breast Cancer
Fudan University 19
Testing effectiveness (Phase 2)Study completedNCT02162446
What this trial is testing

68Ga-OPS202 Study for Diagnostic Imaging of GEP NET

Who this might be right for
Gastroenteropancreatic Neuroendocrine Tumors
Ipsen 12
Testing effectiveness (Phase 2)Study completedNCT02481726
What this trial is testing

68Ga-AlfatideII for the Differential Diagnosis of of Lung Cancer and Lung Tuberculosis by PET/CT

Who this might be right for
Lung CancerLung Tuberculosis
Xijing Hospital 31
Very early researchNot Yet RecruitingNCT07768501
What this trial is testing

S1R Imaging-Based Cryoneurolysis in Chronic Pain

Who this might be right for
Chronic PainMixed Pain (Nociceptive and Neuropathic)
Davidzon, Guido, M.D. 6
Large-scale testing (Phase 3)Looking for participantsNCT07426094
What this trial is testing

PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate Cancer

Who this might be right for
Prostate CancerBrachytherapyStereotactic Body Radiation Therapy (SBRT)+2 more
Affidea Nu-med Center of Oncological DIagnostics and Therapy 600
Testing effectiveness (Phase 2)Looking for participantsNCT05761366
What this trial is testing

Application of 18F-PSMA PET / CT Imaging in Prostate Specific Membrane Antigen Positive Tumor

Who this might be right for
Malignancy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 400
Not applicableUnknownNCT04989010
What this trial is testing

Safety Study of 89Zr-Anti-CLDN18.2 mAbs PET Imaging in Patients With CLDN18.2 Positive Solid Tumors

Who this might be right for
Solid Tumor, Adult
Wuxi No. 4 People's Hospital 20
Not applicableUnknownNCT05165602
What this trial is testing

Evaluation of HER2-targeted Therapy for Gastric Cancer and Establishment and Verification of Monitoring System

Who this might be right for
HER2 Positive Gastric Cancer
Peking University 30
Large-scale testing (Phase 3)Ended earlyNCT01659099
What this trial is testing

GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma CD20 Positive
The Lymphoma Academic Research Organisation 671
Testing effectiveness (Phase 2)Looking for participantsNCT06096870
What this trial is testing

Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy

Who this might be right for
Prostate CancerRecurrent Prostate CancerPET Positive
National Cancer Institute (NCI) 65
Next Page